IDH1 and IDH2 results in AML – Hagop Kantarjian

Hagop Kantarjian, MD of MD Anderson Cancer Center discusses IDH1 and IDH2 results in AML at the Scripps 36th Annual Conference: Clinical Hematology and Oncology in San Diego.